Influenza Archives
Study finds antiviral treatment is largely underused in children with influenza
Nov. 13, 2023—Vanderbilt research finds antiviral medications are underused in young children diagnosed with influenza despite national guidelines supporting their use
Flu season starting late but expected to increase for the holidays
Nov. 8, 2023—The current flu season has started later and more gradually than last year although cases are expected to begin increasing in November before falling off in March.
Flulapalooza 2023
Oct. 5, 2023—This year, 10,603 faculty, staff, postdoc scholars and students were vaccinated at VUMC's Flulapalooza event.
Study explores how often children diagnosed with flu experience serious neuropsychiatric side effects
Jul. 24, 2023—A Vanderbilt study is among the first to quantify how often children diagnosed with flu experience serious neuropsychiatric side effects.
High-dose flu vaccine beneficial for pediatric stem cell transplant patients
Mar. 2, 2023—Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.
Risk of household flu spread skyrocketed during pandemic
Feb. 2, 2023—A Vanderbilt study found that the household spread of flu during the 2021-2022 season was more than twice as high as it was prior to the COVID-19 pandemic.
Flu season came early, hit hard in Tennessee
Dec. 21, 2022—Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.
Flulapalooza
Oct. 6, 2022—Nearly 10,000 faculty, staff, postdoc scholars and students were vaccinated at last week’s Flulapalooza event.
Study tracks limited use of influenza antiviral therapy
Aug. 4, 2022—A Vanderbilt study found that more than half of children diagnosed with influenza and deemed high risk for flu-related complications were given the recommended antiviral treatment.
Study to evaluate nasal flu vaccine for children
Jul. 28, 2022—Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.
Study explores parents’ reluctance to flu, COVID vaccines for children
Apr. 7, 2022—Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.
Study compares kidney injury risk for COVID, flu patients
Mar. 17, 2022—A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.
